TNFRSF8 and lymphoproliferative syndrome: However, without supportive clinical, histopathological and genetic evidence indicative of a lymphoproliferative disorder, TUGSE should be regarded as a reactive lesion rather than part of the CD30 lymphoproliferative spectrum [16,18].